10-K Decoder · All companies

Syndax Pharmaceuticals, Inc.

SNDX · FY2025 · Fiscal year ended Dec 31, 2025 · 10-K filed Feb 2026

Open the dashboardInfographicSummary

FY2025 key figures

$FY2025FY2024Change
Revenue$172M$23.7M+628%
Operating income−$273M−$340M+19.6%
Net income−$285M−$319M+10.5%

Latest quarter: Q3 2026

Form 10-Q · Three months ended Sep 30, 2026 · filed Nov 2, 2026

$Q3 2026Year earlierChange
Revenue$83.3M$45.9M+81.5%
Operating income−$41.9M−$57.4M+27.0%
Net income−$49.4M−$60.7M+18.6%

Q3 2026 dashboardQ3 2026 infographic

Questions

What was Syndax's revenue in FY2025?
$172M in FY2025 (Fiscal year ended Dec 31, 2025), +628% vs $23.7M a year earlier, per its 10-K filed Feb 2026.
Was Syndax profitable in FY2025?
No: net income was −$285M and operating income −$273M in FY2025.
What was Syndax's revenue in Q3 2026?
$83.3M (+81.5% vs a year earlier), per its Form 10-Q filed Nov 2, 2026.